← Open Payments lookup

LAURA BURGESON: Open Payments

NPI 1962467977 · HAYDEN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,070 in 63 payments from 14 companies in 2025. Trend: 2023 $446 · 2024 $867 · 2025 $1,070

Food & beverage: $1,070
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.12$180
AstraZeneca Pharmaceuticals LP8$166
Novartis Pharmaceuticals Corporation7$149
GlaxoSmithKline, LLC.14$139
Novo Nordisk Inc6$122
Amgen Inc.3$67
Ardelyx, Inc.4$63
Calliditas Therapeutics US Inc.2$40
Mannkind Corporation1$36
Vifor Pharma, Inc.2$33

Products named: Kerendia, FARXIGA, BENLYSTA, Ozempic, Vanrafia, IBSRELA, KRYSTEXXA, TARPEYO.

Industry payments across ID — which companies pay providers there.